Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in Oncogene Retrieve available abstracts of 70 articles: HTML format

Single Articles

May 2026
1. YANG MH, Sheth S, Shui B, Grabski IN, et al
   The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium.
   Oncogene. 2026;45:1828-1839.
   PubMed     Abstract available
   
   
   April 2026
2. DEMMLER R, Anchang CG, Yong Y, Ramming A, et al
   Fibroblast dynamics in colorectal cancer: stability, plasticity, and novel markers.
   Oncogene. 2026 Apr 28. doi: 10.1038/s41388-026-03809.
   PubMed     Abstract available
   
   
   
3. LI C, Deng S, Zhuang M, Li T, et al
   MTPN drives noncanonical ERK hyperactivation in colorectal cancer and provides a promising therapeutic approach for precision medicine in CRC.
   Oncogene. 2026 Apr 20. doi: 10.1038/s41388-026-03795.
   PubMed     Abstract available
   
   
   
4. ZHENG Z, Ni Y, Wu M, Ding L, et al
   USP13 stabilizes SOCS1 to reverse alphaPD-1 resistance in MSI-H colorectal cancer.
   Oncogene. 2026 Apr 18. doi: 10.1038/s41388-026-03782.
   PubMed     Abstract available
   
   
   
5. ZHOU Z, La Ferlita A, Palavalli MH, Chen X, et al
   TWIST1 mediated transcriptional activation of SPON2 drives colorectal cancer peritoneal metastasis through stromal cell signaling network.
   Oncogene. 2026 Apr 3. doi: 10.1038/s41388-026-03743.
   PubMed     Abstract available
   
   
   
6. HE H, Yuan J, Wang H, Chen L, et al
   L1TD1 promotes colorectal mucinous adenocarcinoma progression by enhancing ABCC3 mRNA stability.
   Oncogene. 2026;45:1071-1086.
   PubMed     Abstract available
   
   
   
7. KUANG Z, Su Q, Liang W, Shen K, et al
   PRSS22 inhibits HMOX1-mediated ferroptosis and induces osteopontin cleavage to promote M2 macrophage polarization and colitis-associated carcinogenesis.
   Oncogene. 2026;45:1275-1286.
   PubMed     Abstract available
   
   
   March 2026
8. LI C, Liu Q, Shen H, Zou T, et al
   Fusobacterium nucleatum drives colorectal cancer progression through the circPTBP3/miR-760/PUM1 axis.
   Oncogene. 2026 Mar 31. doi: 10.1038/s41388-026-03746.
   PubMed     Abstract available
   
   
   
9. ZHANG H, Tian Y, Xiang Z, Han F, et al
   ZDHHC9-mediated KLF5 palmitoylation enhances the cAMP/PKA/CREB axis to promote colorectal cancer progression.
   Oncogene. 2026 Mar 25. doi: 10.1038/s41388-026-03724.
   PubMed     Abstract available
   
   
   
10. PENG Z, Ma B, Song Z, Zhao Y, et al
    PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression.
    Oncogene. 2026 Mar 6. doi: 10.1038/s41388-026-03707.
    PubMed     Abstract available
    
    
    
11. CABALLERO-RUIZ B, Bordone R, Coni S, Gkotsi DS, et al
    Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop.
    Oncogene. 2026;45:1013-1025.
    PubMed     Abstract available
    
    
    February 2026
12. ACEVEDO M, Do F, El-Mortada F, Tanguay PL, et al
    The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver beta-catenin in colorectal cancer.
    Oncogene. 2026 Feb 19. doi: 10.1038/s41388-026-03695.
    PubMed     Abstract available
    
    
    January 2026
13. WANG B, Zhang S, Guo Y, Gao W, et al
    Correction: CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.
    Oncogene. 2026 Jan 21. doi: 10.1038/s41388-026-03677.
    PubMed    
    
    
    
14. SU J, Zhao M, Feng W, Lin Y, et al
    TAF1 acetyltransferase promotes colorectal carcinoma metastasis by catalyzing beta-hydroxybutyrylation of KCTD9.
    Oncogene. 2026;45:87-103.
    PubMed     Abstract available
    
    
    December 2025
15. WANG H, Ge L, Li J, Zhong K, et al
    NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair.
    Oncogene. 2025 Dec 27. doi: 10.1038/s41388-025-03661.
    PubMed     Abstract available
    
    
    
16. HUANG M, Xie W, Wu M, Ou Z, et al
    KRT81 promotes metastasis of colorectal cancer by acting as a protein scaffold for ezrin.
    Oncogene. 2025 Dec 17. doi: 10.1038/s41388-025-03665.
    PubMed     Abstract available
    
    
    
17. YANG LP, Huang JQ, Yeung CW, Zhang QH, et al
    Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis.
    Oncogene. 2025 Dec 2. doi: 10.1038/s41388-025-03638.
    PubMed     Abstract available
    
    
    November 2025
18. LV M, Hu C, Li J, Zhang Y, et al
    Serotonin receptor type 7 (5-HT7) promotes colorectal cancer progression by activating Wnt/beta-catenin signaling via interacting with CK1epsilon.
    Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03645.
    PubMed     Abstract available
    
    
    
19. SMABERS LP, Nienhuis HH, de Leng WWJ, Roepman P, et al
    Clinical implications of whole genome sequencing in metastatic colorectal cancer.
    Oncogene. 2025 Nov 7. doi: 10.1038/s41388-025-03618.
    PubMed     Abstract available
    
    
    October 2025
20. HU Y, Liu W, Qiang D, Huang K, et al
    Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer.
    Oncogene. 2025 Oct 19. doi: 10.1038/s41388-025-03599.
    PubMed     Abstract available
    
    
    
21. HUANG M, Qin B, Xie Z, Zhou R, et al
    Publisher Correction: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway.
    Oncogene. 2025 Oct 8. doi: 10.1038/s41388-025-03592.
    PubMed    
    
    
    
22. LANZLOTH R, Harris NL, Cannon AM, Kaplan MH, et al
    Mast cells interact directly with colorectal cancer cells to promote epithelial-to-mesenchymal transition.
    Oncogene. 2025 Oct 2. doi: 10.1038/s41388-025-03589.
    PubMed     Abstract available
    
    
    September 2025
23. LIN P, Lin C, Teng Z, Liu S, et al
    USP10-mediated Ku70/80 stabilization inhibits PANoptosis and promotes chemoresistance in colorectal cancer.
    Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03570.
    PubMed     Abstract available
    
    
    
24. YIN Y, Ming L, Qin Y, Tang J, et al
    RAB22A triggers intercellular chemoresistance transmission in colorectal cancer by promoting exosome release via the PKM2-pSNAP23 axis.
    Oncogene. 2025 Sep 16. doi: 10.1038/s41388-025-03566.
    PubMed     Abstract available
    
    
    
25. REN Y, Chen J, Zhan X, Sheng S, et al
    Correction: Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism.
    Oncogene. 2025 Sep 10. doi: 10.1038/s41388-025-03540.
    PubMed    
    
    
    
26. TRAN TQ, Duysak T, Kim K, Dang GC, et al
    Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella.
    Oncogene. 2025;44:3449-3460.
    PubMed     Abstract available
    
    
    August 2025
27. STRELEZ C, Battaglin F, Perez R, Yang Y, et al
    GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer.
    Oncogene. 2025 Aug 24. doi: 10.1038/s41388-025-03546.
    PubMed     Abstract available
    
    
    
28. HUANG M, Qin B, Xie Z, Zhou R, et al
    RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway.
    Oncogene. 2025 Aug 23. doi: 10.1038/s41388-025-03535.
    PubMed     Abstract available
    
    
    
29. WANG YN, Zeng ZL, Lu J, Wang Y, et al
    Correction: CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
    Oncogene. 2025 Aug 7. doi: 10.1038/s41388-025-03508.
    PubMed    
    
    
    
30. IDEN JA, Ben-Califa N, Naim A, Liron T, et al
    Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humans.
    Oncogene. 2025;44:2504-2514.
    PubMed     Abstract available
    
    
    July 2025
31. REN Y, Chen J, Zhan X, Sheng S, et al
    Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism.
    Oncogene. 2025 Jul 25. doi: 10.1038/s41388-025-03498.
    PubMed     Abstract available
    
    
    
32. TARRADO-CASTELLARNAU M, Foguet C, Tarrago-Celada J, Palobart M, et al
    Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells.
    Oncogene. 2025 Jul 22. doi: 10.1038/s41388-025-03495.
    PubMed     Abstract available
    
    
    
33. CONG B, Thakur T, Uribe AH, Stamou E, et al
    Colon cancer cells evade drug action by enhancing drug metabolism.
    Oncogene. 2025 Jul 10. doi: 10.1038/s41388-025-03472.
    PubMed     Abstract available
    
    
    
34. HAN H, Li Y, Lin Z, Ma X, et al
    ALKBH5 suppresses m(6)A mRNA modification of FOXM1 to drive Cetuximab resistance in KRAS-mutant colorectal cancer.
    Oncogene. 2025 Jul 7. doi: 10.1038/s41388-025-03490.
    PubMed     Abstract available
    
    
    
35. JAYACHANDRAN P, Elliott A, Soni S, Battaglin F, et al
    Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer.
    Oncogene. 2025 Jul 4. doi: 10.1038/s41388-025-03484.
    PubMed     Abstract available
    
    
    
36. ZHAO M, Nie J, Ye A, Liu C, et al
    Impaired autophagy by cepharanthine induces immunogenic cell death and enhances anti-PD-1 response in MSS-type colorectal cancer.
    Oncogene. 2025 Jul 3. doi: 10.1038/s41388-025-03488.
    PubMed     Abstract available
    
    
    June 2025
37. WU H, Hu X, Wang Y, Zhu X, et al
    RBM5 recruiting MGC32805 in a sandwich mode and inducing DeltaFAS neoantigen and triggering FAS properties switch: implication in colorectal cancer.
    Oncogene. 2025 Jun 26. doi: 10.1038/s41388-025-03390.
    PubMed     Abstract available
    
    
    
38. GUO ST, Jiang CC, Wang GP, Li YP, et al
    Correction: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
    Oncogene. 2025 Jun 3. doi: 10.1038/s41388-025-03446.
    PubMed    
    
    
    
39. GU J, Xu X, Li X, Yue L, et al
    Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.
    Oncogene. 2025 Jun 2. doi: 10.1038/s41388-025-03439.
    PubMed    
    
    
    
40. BAI X, Duan T, Shao J, Zhang Y, et al
    CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis.
    Oncogene. 2025;44:1678-1693.
    PubMed     Abstract available
    
    
    May 2025
41. QU S, Feng B, Xing M, Qiu Y, et al
    PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer.
    Oncogene. 2025 May 30. doi: 10.1038/s41388-025-03457.
    PubMed     Abstract available
    
    
    
42. PAN D, Hu J, Li G, Gao X, et al
    BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer.
    Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03453.
    PubMed     Abstract available
    
    
    April 2025
43. WOUTERS VM, Helderman RFCPA, Cameron K, van der Hooff SR, et al
    CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer.
    Oncogene. 2025 Apr 6. doi: 10.1038/s41388-025-03365.
    PubMed     Abstract available
    
    
    March 2025
44. TAIRA A, Aavikko M, Katainen R, Kaasinen E, et al
    Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer.
    Oncogene. 2025 Mar 18. doi: 10.1038/s41388-025-03326.
    PubMed     Abstract available
    
    
    
45. WANG B, Zhang S, Guo Y, Gao W, et al
    CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.
    Oncogene. 2025 Mar 13. doi: 10.1038/s41388-025-03331.
    PubMed     Abstract available
    
    
    February 2025
46. SHENG Z, Luo S, Huang L, Deng YN, et al
    SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis.
    Oncogene. 2025 Feb 23. doi: 10.1038/s41388-025-03302.
    PubMed     Abstract available
    
    
    
47. YAN Z, He L, Yuan J, Niu Y, et al
    The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.
    Oncogene. 2025 Feb 16. doi: 10.1038/s41388-025-03307.
    PubMed     Abstract available
    
    
    
48. ZHANG J, Zhai J, Wong CC, Chen H, et al
    Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
    PubMed    
    
    
    
49. RUAN DY, Li T, Wang YN, Meng Q, et al
    Correction: FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
    Oncogene. 2025 Feb 4. doi: 10.1038/s41388-025-03287.
    PubMed    
    
    
    January 2025
50. REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al
    Correction: USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
    Oncogene. 2025 Jan 22. doi: 10.1038/s41388-024-03262.
    PubMed    
    
    
    December 2024
51. LIAO Y, Yang R, Wang B, Ruan Y, et al
    Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.
    Oncogene. 2024 Dec 26. doi: 10.1038/s41388-024-03255.
    PubMed     Abstract available
    
    
    November 2024
52. ZHUANG M, Liu J, Li Y, Zhang J, et al
    PD-L1 promotes tumor metastasis by regulating the infiltration of FGFBP2(+)Tm cells in colorectal cancer.
    Oncogene. 2024 Nov 18. doi: 10.1038/s41388-024-03223.
    PubMed     Abstract available
    
    
    
53. WEN M, Qiu Y, Wang M, Tang F, et al
    Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03207.
    PubMed     Abstract available
    
    
    
54. DUYSAK T, Kim K, Yun M, Jeong JH, et al
    Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum.
    Oncogene. 2024;43:3378-3387.
    PubMed     Abstract available
    
    
    
55. BORDONE R, Ivy DM, D'Amico R, Barba M, et al
    MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.
    Oncogene. 2024;43:3349-3365.
    PubMed     Abstract available
    
    
    October 2024
56. BORDING T, Janik T, Bischoff P, Morkel M, et al
    GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy.
    Oncogene. 2024 Oct 29. doi: 10.1038/s41388-024-03200.
    PubMed     Abstract available
    
    
    
57. REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al
    USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
    Oncogene. 2024 Oct 23. doi: 10.1038/s41388-024-03141.
    PubMed     Abstract available
    
    
    
58. LIN W, Xu L, Li Y, Li J, et al
    Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing.
    Oncogene. 2024 Oct 13. doi: 10.1038/s41388-024-03189.
    PubMed     Abstract available
    
    
    
59. HAN F, Zhou X, Liu L, Yang B, et al
    GLTSCR1 deficiency promotes colorectal cancer development through regulating non-homologous end joining.
    Oncogene. 2024 Oct 11. doi: 10.1038/s41388-024-03179.
    PubMed     Abstract available
    
    
    September 2024
60. XU H, Wang T, Nie H, Sun Q, et al
    USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28.
    Oncogene. 2024 Sep 29. doi: 10.1038/s41388-024-03178.
    PubMed     Abstract available
    
    
    
61. SUN Z, Dang P, Guo Y, Liu S, et al
    Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1 protein degradation.
    Oncogene. 2024 Sep 28. doi: 10.1038/s41388-024-03155.
    PubMed     Abstract available
    
    
    
62. TANG W, Yang Y, Fu Z, Xu W, et al
    The RNA helicase DDX21 activates YAP to promote tumorigenesis and is transcriptionally upregulated by beta-catenin in colorectal cancer.
    Oncogene. 2024 Sep 17. doi: 10.1038/s41388-024-03160.
    PubMed     Abstract available
    
    
    
63. CHURCHHOUSE AMD, Billard CV, Suzuki T, Pohl SOG, et al
    Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNgamma induction of IDO1 expression.
    Oncogene. 2024 Sep 7. doi: 10.1038/s41388-024-03135.
    PubMed     Abstract available
    
    
    August 2024
64. GUPTA A, Avadhanula S, Bashyam MD
    Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability.
    Oncogene. 2024;43:2449-2462.
    PubMed     Abstract available
    
    
    July 2024
65. LI X, Chen Y, Lu R, Hu M, et al
    Correction: Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis.
    Oncogene. 2024 Jul 15. doi: 10.1038/s41388-024-03101.
    PubMed    
    
    
    June 2024
66. GU J, Xu X, Li X, Yue L, et al
    Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.
    Oncogene. 2024 Jun 18. doi: 10.1038/s41388-024-03080.
    PubMed     Abstract available
    
    
    
67. FENG M, Chai C, Hao X, Lai X, et al
    Inherited KDM6A(A649T) facilitates tumor-immune escape and exacerbates colorectal signet-ring cell carcinoma outcomes.
    Oncogene. 2024;43:1757-1768.
    PubMed     Abstract available
    
    
    April 2024
68. CAO N, Zhang F, Yin J, Zhang J, et al
    LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
    Oncogene. 2024 Apr 11. doi: 10.1038/s41388-024-02996.
    PubMed     Abstract available
    
    
    
69. WU Q, Wang Z, Chen S, She X, et al
    USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy.
    Oncogene. 2024 Apr 2. doi: 10.1038/s41388-024-03009.
    PubMed     Abstract available
    
    
    March 2024
70. LI X, Chen Y, Lu R, Hu M, et al
    Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis.
    Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03008.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum